Genetic variation of the brca1 and BRCA2 genes in macedonian patients

Balkan Journal of Medical Genetics

Volumn 15, Issue SUPPL., 2012, Pages 81-85

  Maleva, I ^a   Madjunkova, S ^a   Bozhinovski, G ^a   Smickova, E ^b   Kondov, G ^c   Spiroski, Z ^c   Arsovski, A ^d   Plaseska Karanfilska, D ^a  

^a MACEDONIAN ACADEMY OF SCIENCES AND ARTS   (Macedonia)

^b University Clinic of Radiotherapy and Oncology   (Macedonia)

^c Clinic for Orthopaedic Surgery   (Macedonia)

^d In Vitro Fertilisation Centre   (Macedonia)

Author keywords

BRCA1 and BRCA2 genes; Breast cancer; Macedonian patients; Polymorphisms

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

BREAST CANCER; CANCER RISK; CAPILLARY ELECTROPHORESIS; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENE REARRANGEMENT; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; OVARY CANCER; POINT MUTATION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84879639217     PISSN: None     EISSN: 13110160     Source Type: Journal    
DOI: 10.2478/v10034-012-0025-8     Document Type: Conference Paper

References (14)

1. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994; 266(5182): 66-71 (Pubitemid 24345325)
2. Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995; 378(6559): 789-792 (Pubitemid 26004412)
3. Walsh T, King MC. Ten genes for inherited breast cancer. Cancer Cell. 2007; 11(2): 103-5 (Pubitemid 46209856)
4. Fackenthal JD, Olopade OI. Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer. 2007; 7(12): 937-948 (Pubitemid 350165853)
5. Ferla R, Calo V, Cascio S, et al. Founder mutations in BRCA1 and BRCA2 genes. Ann Oncol. 2007; 18 (Suppl 6): vi93-98
6. Balmana J, Diez O, Castiglione M. BRCA in breast cancer: ESMO clinical recommendations. Ann Oncol. 2009; 20(Suppl 4): 19-20
7. De Greve J, Sermijn E, De Brakeleer S, Ren Z, Teugels E. Hereditary breast cancer: from bench to bedside. Curr Opin Oncol. 2008; 20(6): 605-613
8. Rouleau M, Patel A, Hendzel MJ, Kaufmann SH, Poirier GG. PARP inhibition: PARP1 and beyond. Nat Rev Cancer. 2010; 10(4): 293-301
9. Byrski T, Gronwald J, Huzarski T, et al. Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy. J Clin Oncol. 2010; 28(3): 375-379
10. Neuhausen SL. Founder populations and their uses for breast cancer genetics. Breast Cancer Res. 2000; 2(2): 77-81 (Pubitemid 32223567)
11. Freedman ML, Penney KL, Stram DO, et al. A haplotype- based case-control study of BRCA1 and sporadic breast cancer risk. Cancer Res. 2005; 65(16): 7516-7522 (Pubitemid 41161288)
12. Ewald IP, Ribeiro PL, Palmero EI, Cossio SL, Giugliani R, Ashton-Prolla P. Genomic rearrangements in BRCA1 and BRCA2: A literature review. Genet Mol Biol. 2009; 32(3): 437-446
13. Cox DG, Kraft P, Hankinson SE, Hunter DJ. Haplotype analysis of common variants in the BRCA1 gene and risk of sporadic breast cancer. Breast Cancer Res. 2005; 7(2): R171-R175
14. Qiu LX, Yao L, Xue K, et al. BRCA2 N372H polymorphism and breast cancer susceptibility: a metaanalysis involving 44,903 subjects. Breast Cancer Res Treat. 2010; 123(2): 487-490.